| Common Stock, Shares Authorized |
2B |
shares |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
5.88M |
shares |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
15.8M |
USD |
+68717% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
1.01M |
USD |
+47.4% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
937K |
USD |
+48% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
-100% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
0 |
shares |
-100% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
23.6M |
USD |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
-100% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
1.01M |
USD |
+47.4% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q4 2024 |
FY 2024 |